These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32491828)

  • 1. Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice.
    Madison CA; Arora M; Kumar MNVR; Eitan S
    ACS Chem Neurosci; 2020 Jul; 11(13):1955-1964. PubMed ID: 32491828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow-sustained delivery of naloxone reduces typical naloxone-induced precipitated opioid withdrawal effects in male morphine-dependent mice.
    Lewter LA; Johnson MC; Treat AC; Kassick AJ; Averick S; Kolber BJ
    J Neurosci Res; 2022 Jan; 100(1):339-352. PubMed ID: 32772457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice.
    Zhang G; Wu X; Zhang YM; Liu H; Jiang Q; Pang G; Tao X; Dong L; Stackman RW
    Neuropharmacology; 2016 Feb; 101():246-54. PubMed ID: 26432939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents.
    Doyle TM; Hutchinson MR; Braden K; Janes K; Staikopoulos V; Chen Z; Neumann WL; Spiegel S; Salvemini D
    J Neuroinflammation; 2020 Oct; 17(1):314. PubMed ID: 33092620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.
    McLane VD; Bergquist I; Cormier J; Barlow DJ; Houseknecht KL; Bilsky EJ; Cao L
    Life Sci; 2017 Sep; 185():1-7. PubMed ID: 28723417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing different paradigms of morphine withdrawal on sleep behavior in male and female C57BL/6J mice.
    Bedard ML; Lord JS; Perez PJ; Bravo IM; Teklezghi AT; Tarantino LM; Diering GH; McElligott ZA
    Behav Brain Res; 2023 Jun; 448():114441. PubMed ID: 37075956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent naloxone-induced morphine withdrawal symptoms in opioid-dependent males-a double-blinded, randomized study.
    Weisshaar S; Brandt L; Litschauer B; Sheik-Rezaei S; Moser L; Nirnberger G; Kühberger E; Bauer U; Firbas C; Gouya G; Wolzt M; Fischer G
    Br J Clin Pharmacol; 2020 Aug; 86(8):1610-1619. PubMed ID: 32145041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice.
    Cheaha D; Reakkamnuan C; Nukitram J; Chittrakarn S; Phukpattaranont P; Keawpradub N; Kumarnsit E
    J Ethnopharmacol; 2017 Aug; 208():129-137. PubMed ID: 28687506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
    Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
    J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
    de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
    Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal.
    Lewanowitsch T; Irvine RJ
    Eur J Pharmacol; 2002 Jun; 445(1-2):61-7. PubMed ID: 12065195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects.
    Vashchinkina E; Piippo O; Vekovischeva O; Krupitsky E; Ilyuk R; Neznanov N; Kazankov K; Zaplatkin I; Korpi ER
    Addict Biol; 2018 May; 23(3):945-958. PubMed ID: 28741741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
    Zamani N; Buckley NA; Hassanian-Moghaddam H
    Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.
    Dahan A; Franko TS; Carroll JW; Craig DS; Crow C; Galinkin JL; Garrity JC; Peterson J; Rausch DB
    Front Public Health; 2024; 12():1346109. PubMed ID: 38481848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
    Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
    Pinelli A; Trivulzio S
    J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.